Ann BeasleyChief Compliance Officer at Zai Lab
Ann E. Beasley, JD, is the Chief Compliance Officer at Zai Lab. She has over 20 years of healthcare and life sciences experience including working in-house for companies in pharmaceutical, biologics, vaccine, device and genetic testing. She has practiced in both legal and compliance departments and was recently the Chief Compliance Officer and Senior Vice President at Biogen and then shared her many learnings as a compliance professional through consulting as a Director at Guidehouse in its Life Sciences Governance, Risk Management and Compliance practice. Ann has significant international experience having built and led global compliance programs for major pharmaceutical and biotechnology companies, including developing the organizational infrastructure of the function and the individual skill development of compliance professionals. She has built and managed local and global corporate compliance programs and initiated specific projects including performing complex investigations, building investigation protocols, Codes of Conduct and other structural elements of a Corporate Compliance Program. These elements include risk assessments, policy development, training and communications, and developing robust monitoring plans and requisite data analytics and feedback to management. She also has extensive experience in implementation of business processes and controls and overall program assessment. She has specific legal and regulatory expertise in advertising and promotion, kick-backs, anti-bribery and anti-corruption, grants and charitable contributions, conflicts of interest, healthcare practitioner fee for service arrangements, spend transparency, Phase IV clinical trial processes, Investigator Initiated Studies, issues related to medical affairs practices including advising on field interactions, publication processes and use, and secondary research. Ann is also very familiar with US and international privacy regulations. Ann has run executive management corporate compliance committees and presented regularly at Board and Board Committee meetings.